{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:02:57Z","timestamp":1777438977531,"version":"3.51.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,6,4]],"date-time":"2011-06-04T00:00:00Z","timestamp":1307145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00213-011-2368-3","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T14:12:24Z","timestamp":1307110344000},"page":"733-748","source":"Crossref","is-referenced-by-count":12,"title":["Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers"],"prefix":"10.1007","volume":"218","author":[{"given":"Tanja","family":"Veselinovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Schorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Vernaleken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Schiffl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Hiemke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Zernig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Gur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Gr\u00fcnder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,4]]},"reference":[{"issue":"Suppl 1","key":"2368_CR1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S1461145704004110","volume":"7","author":"A Abi-Dargham","year":"2004","unstructured":"Abi-Dargham A (2004) Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol 7(Suppl 1):S1\u2013S5","journal-title":"Int J Neuropsychopharmacol"},{"key":"2368_CR2","volume-title":"Diagnostic and Statistical Manual of Mental Disorders\u2014DSM-III","author":"American Psychiatric Association","year":"1980","unstructured":"American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders\u2014DSM-III, 3rd edn. American Psychiatric Association, Washington","edition":"3"},{"issue":"3","key":"2368_CR3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/schbul\/19.3.609","volume":"19","author":"AG Awad","year":"1993","unstructured":"Awad AG (1993) Subjective response to neuroleptics in schizophrenia. Schizophr Bull 19(3):609\u2013618","journal-title":"Schizophr Bull"},{"issue":"13","key":"2368_CR4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00023210-200418130-00004","volume":"18","author":"AG Awad","year":"2004","unstructured":"Awad AG, Voruganti LN (2004) Impact of atypical antipsychotics on quality of life in patients with schizophrenia. CNS Drugs 18(13):877\u2013893","journal-title":"CNS Drugs"},{"key":"2368_CR5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0447.2005.00539.x","volume":"427","author":"AG Awad","year":"2005","unstructured":"Awad AG, Voruganti LN (2005) Neuroleptic dysphoria: revisiting the concept 50\u00a0years later. Acta Psychiatr Scand Suppl 427:6\u201313","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"3","key":"2368_CR6","first-page":"354","volume":"58","author":"FJ Ayd Jr","year":"1958","unstructured":"Ayd FJ Jr (1958) Drug-induced depression; fact of fallacy. N Y State J Med 58(3):354\u2013356","journal-title":"N Y State J Med"},{"key":"2368_CR7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","volume":"154","author":"TR Barnes","year":"1989","unstructured":"Barnes TR (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672\u2013676","journal-title":"Br J Psychiatry"},{"issue":"2","key":"2368_CR8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1076\/jhin.12.2.207.15535","volume":"12","author":"AA Baumeister","year":"2003","unstructured":"Baumeister AA, Hawkins MF, Uzelac SM (2003) The myth of reserpine-induced depression: role in the historical development of the monoamine hypothesis. J Hist Neurosci 12(2):207\u2013220","journal-title":"J Hist Neurosci"},{"issue":"3","key":"2368_CR9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0447.1981.tb00676.x","volume":"63","author":"P Bech","year":"1981","unstructured":"Bech P, Allerup P, Gram LF, Reisby N, Rosenberg R, Jacobsen O, Nagy A (1981) The Hamilton depression scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand 63(3):290\u2013299","journal-title":"Acta Psychiatr Scand"},{"key":"2368_CR10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"A Beck","year":"1961","unstructured":"Beck A, Ward C, Mendelson M, Mock J, Erbaugh (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561\u2013571","journal-title":"Arch Gen Psychiatry"},{"key":"2368_CR11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1192\/bjp.131.2.222b","volume":"131","author":"RH Belmaker","year":"1977","unstructured":"Belmaker RH, Wald D (1977) Haloperidol in normals. Br J Psychiatry 131:222\u2013223","journal-title":"Br J Psychiatry"},{"issue":"3","key":"2368_CR12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00004714-198606000-00013","volume":"6","author":"JL Berlant","year":"1986","unstructured":"Berlant JL (1986) Neuroleptics and reserpine in refractory psychoses. J Clin Psychopharmacol 6(3):180\u2013184","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"2368_CR13","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1371\/journal.pmed.0020141","volume":"2","author":"D Bhugra","year":"2005","unstructured":"Bhugra D (2005) The global prevalence of schizophrenia. PLoS Med 2(5):e141, quiz e175","journal-title":"PLoS Med"},{"issue":"1\u20132","key":"2368_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0920-9964(01)00185-2","volume":"56","author":"RA Bressan","year":"2002","unstructured":"Bressan RA, Costa DC, Jones HM, Ell PJ, Pilowsky LS (2002) Typical antipsychotic drugs\u2014D(2) receptor occupancy and depressive symptoms in schizophrenia. Schizophr Res 56(1\u20132):31\u201336","journal-title":"Schizophr Res"},{"issue":"7","key":"2368_CR15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1176\/appi.ajp.161.7.1211","volume":"161","author":"AL Brody","year":"2004","unstructured":"Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P, Lee GS, Huang J, Hahn EL, Mandelkern MA (2004) Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161(7):1211\u20131218","journal-title":"Am J Psychiatry"},{"key":"2368_CR16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00005053-199802000-00002","volume":"186","author":"S Browne","year":"1998","unstructured":"Browne S, Garavan J, Gervin M, Roe M, Larkin C, O'Callaghan E (1998) Quality of life in schizophrenia: insight and subjective response to neuroleptics. J Nerv Ment Dis 186:74\u201378","journal-title":"J Nerv Ment Dis"},{"issue":"4","key":"2368_CR17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/schbul\/sbl057","volume":"33","author":"RW Buchanan","year":"2007","unstructured":"Buchanan RW (2007) Persistent negative symptoms in schizophrenia: an overview. Schizophr Bull 33(4):1013\u20131022","journal-title":"Schizophr Bull"},{"issue":"4287","key":"2368_CR18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1126\/science.847477","volume":"196","author":"DR Burt","year":"1977","unstructured":"Burt DR, Creese I, Snyder SH (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196(4287):326\u2013328","journal-title":"Science"},{"issue":"5","key":"2368_CR19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1176\/ajp.145.5.578","volume":"145","author":"WT Carpenter Jr","year":"1988","unstructured":"Carpenter WT Jr, Heinrichs DW, Wagman AM (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145(5):578\u2013583","journal-title":"Am J Psychiatry"},{"issue":"4","key":"2368_CR20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1527-3458.2004.tb00030.x","volume":"10","author":"MA Davies","year":"2004","unstructured":"Davies MA, Sheffler DJ, Roth BL (2004) Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology. CNS Drug Rev 10(4):317\u2013336","journal-title":"CNS Drug Rev"},{"issue":"2","key":"2368_CR21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.160.2.303","volume":"160","author":"L Haan De","year":"2003","unstructured":"De Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D (2003) Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am J Psychiatry 160(2):303\u2013309","journal-title":"Am J Psychiatry"},{"issue":"5","key":"2368_CR22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/070674370404900503","volume":"49","author":"L Haan De","year":"2004","unstructured":"De Haan L, Lavalaye J, van Bruggen M, van Nimwegen L, Booij J, van Amelsvoort T, Linszen D (2004) Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications. Can J Psychiatry 49(5):290\u2013296","journal-title":"Can J Psychiatry"},{"issue":"9","key":"2368_CR23","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1176\/appi.ajp.162.9.1755","volume":"162","author":"L Haan De","year":"2005","unstructured":"De Haan L, Booij J, Lavalye J, van Amelsvoort T, Linszen D (2005) Subjective experiences during dopamine depletion. Am J Psychiatry 162(9):1755","journal-title":"Am J Psychiatry"},{"key":"2368_CR24","unstructured":"Dilling H, Mombour W, Schmidt MH (2002) Internationale Klassifikation psychischer St\u00f6rungen. ICD-10 Kapitel V (F). Klinisch-diagnostische Leitlinien (Auflage: 5). Huber, Bern"},{"key":"2368_CR25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0924-9338(96)80320-8","volume":"8","author":"S Dollfus","year":"1995","unstructured":"Dollfus S, Petit M (1995) Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in acute phase. Eur Psychiatry 8:97\u2013106","journal-title":"Eur Psychiatry"},{"issue":"8","key":"2368_CR26","first-page":"362","volume":"18","author":"C Domecq","year":"1980","unstructured":"Domecq C, Naranjo CA, Ruiz I, Busto U (1980) Sex-related variations in the frequency and characteristics of adverse drug reactions. Int J Clin Pharmacol Ther Toxicol 18(8):362\u2013366","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"3","key":"2368_CR27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","volume":"64","author":"BW Dunlop","year":"2007","unstructured":"Dunlop BW, Nemeroff CB (2007) The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64(3):327\u2013337","journal-title":"Arch Gen Psychiatry"},{"key":"2368_CR28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","volume":"49","author":"L Farde","year":"1992","unstructured":"Farde L, Nordstr\u00f6m A-L, Wiesel F-A, Pauli S, Halldin C, Sedvall G (1992) Positron emission tomographic analysis of central D1- and D2-dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine\u2014relation to extrapyramidal side effects. Arch Gen Psychiatry 49:538\u2013544","journal-title":"Arch Gen Psychiatry"},{"key":"2368_CR29","unstructured":"First MB, Spitzer RL, Gibbon M, et al. (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I\/NP). Biometrics Research, New York State Psychiatric Institute. New York, NY"},{"issue":"1","key":"2368_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002139900333","volume":"149","author":"PB Fitzgerald","year":"2000","unstructured":"Fitzgerald PB, Kapur S, Remington G, Roy P, Zipursky RB (2000) Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levels. Psychopharmacology (Berl) 149(1):1\u20135","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"2368_CR31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0161-813X(02)00109-2","volume":"24","author":"JS Fowler","year":"2003","unstructured":"Fowler JS, Logan J, Wang GJ, Volkow ND (2003) Monoamine oxidase and cigarette smoking. Neurotoxicology 24(1):75\u201382","journal-title":"Neurotoxicology"},{"issue":"10","key":"2368_CR32","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archpsyc.60.10.974","volume":"60","author":"G Gr\u00fcnder","year":"2003","unstructured":"Gr\u00fcnder G, Carlsson A, Wong DF (2003) Mechanism of new antipsychotic medications: occupancy is not just antagonism. Arch Gen Psychiatry 60(10):974\u2013977","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"2368_CR33","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1176\/appi.ajp.2008.07101574","volume":"165","author":"G Gr\u00fcnder","year":"2008","unstructured":"Gr\u00fcnder G, Fellows C, Janouschek H, Veselinovic T, Boy C, Br\u00f6cheler A, Kirschbaum KM, Hellmann S, Spreckelmeyer KM, Hiemke C, R\u00f6sch F, Schaefer WM, Vernaleken I (2008) Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study. Am J Psychiatry 165(8):988\u2013995","journal-title":"Am J Psychiatry"},{"issue":"2","key":"2368_CR34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1192\/bjp.164.2.177","volume":"164","author":"SM Halstead","year":"1994","unstructured":"Halstead SM, Barnes TR, Speller JC (1994) Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia. Br J Psychiatry 164(2):177\u2013183","journal-title":"Br J Psychiatry"},{"key":"2368_CR35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2368_CR36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1192\/bjp.172.5.376","volume":"172","author":"D Healy","year":"1998","unstructured":"Healy D, Savage M (1998) Reserpine exhumed. Br J Psychiatry 172:376\u2013378","journal-title":"Br J Psychiatry"},{"key":"2368_CR37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1242\/jeb.196.1.251","volume":"196","author":"JP Henry","year":"1994","unstructured":"Henry JP, Botton D, Sagne C, Isambert MF, Desnos C, Blanchard V, Raisman-Vozari R, Krejci E, Massoulie J, Gasnier B (1994) Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules. J Exp Biol 196:251\u2013262","journal-title":"J Exp Biol"},{"issue":"10","key":"2368_CR38","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","volume":"63","author":"PB Jones","year":"2006","unstructured":"Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW (2006) Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 63(10):1079\u20131087","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"2368_CR39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1471-4159.2000.0740263.x","volume":"74","author":"K Kannari","year":"2000","unstructured":"Kannari K, Tanaka H, Maeda T, Tomiyama M, Suda T, Matsunaga M (2000) Reserpine pretreatment prevents increases in extracellular striatal dopamine following l-DOPA administration in rats with nigrostriatal denervation. J Neurochem 74(1):263\u2013269","journal-title":"J Neurochem"},{"issue":"1","key":"2368_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-3223(92)90137-O","volume":"32","author":"S Kapur","year":"1992","unstructured":"Kapur S, Mann JJ (1992) Role of the dopaminergic system in depression. Biol Psychiatry 32(1):1\u201317","journal-title":"Biol Psychiatry"},{"issue":"7","key":"2368_CR41","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1176\/ajp.153.7.948","volume":"153","author":"S Kapur","year":"1996","unstructured":"Kapur S, Remington G, Jones C, Wilson A, DaSilva J, Houle S, Zipursky R (1996) High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. Am J Psychiatry 153(7):948\u2013950","journal-title":"Am J Psychiatry"},{"issue":"2","key":"2368_CR42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261\u2013276","journal-title":"Schizophr Bull"},{"issue":"3","key":"2368_CR43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/15622970701361255","volume":"9","author":"KM Kirschbaum","year":"2008","unstructured":"Kirschbaum KM, Muller MJ, Malevani J, Mobascher A, Burchardt C, Piel M, Hiemke C (2008) Serum levels of aripiprazole and dehydroaripiprazole, clinical response, and side effects. World J Biol Psychiatry 9(3):212\u2013218","journal-title":"World J Biol Psychiatry"},{"issue":"8","key":"2368_CR44","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1176\/ajp.136.8.1088","volume":"136","author":"BB Kumar","year":"1979","unstructured":"Kumar BB (1979) An unusual case of akathisia. Am J Psychiatry 136(8):1088","journal-title":"Am J Psychiatry"},{"issue":"3","key":"2368_CR45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1055\/s-2007-1014665","volume":"21","author":"G Laakmann","year":"1988","unstructured":"Laakmann G, Blaschke D, Hippius H, Schewe S (1988) Double-blind randomized trial of the benzodiazepine derivative metaclazepam as compared with placebo treatment of outpatients with anxiety syndromes. Pharmacopsychiatry 21(3):136\u2013143","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"2368_CR46","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0031-6997(25)06843-7","volume":"32","author":"SZ Langer","year":"1980","unstructured":"Langer SZ (1980) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32(4):337\u2013362","journal-title":"Pharmacol Rev"},{"issue":"3","key":"2368_CR47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0893-133X(97)00043-2","volume":"17","author":"M Laruelle","year":"1997","unstructured":"Laruelle M, D'Souza CD, Baldwin RM, Abi-Dargham A, Kanes SJ, Fingado CL, Seibyl JP, Zoghbi SS, Bowers MB, Jatlow P, Charney DS, Innis RB (1997) Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology 17(3):162\u2013174","journal-title":"Neuropsychopharmacology"},{"key":"2368_CR48","volume-title":"Mehrfachwahl-Wortschatz-Intelligenztest MWT-B (Multiple-choice intelligence test)","author":"S Lehrl","year":"1989","unstructured":"Lehrl S (1989) Mehrfachwahl-Wortschatz-Intelligenztest MWT-B (Multiple-choice intelligence test). Perimed, Erlangen"},{"issue":"7","key":"2368_CR49","first-page":"522","volume":"74","author":"G Lemieux","year":"1956","unstructured":"Lemieux G, Davignon A, Genest J (1956) Depressive states during Rauwolfia therapy for arterial hypertension: a report of 30 cases. Can Med Assoc J 74(7):522\u2013526","journal-title":"Can Med Assoc J"},{"key":"2368_CR50","doi-asserted-by":"crossref","unstructured":"Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G (2006) Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Health Technol Assess 10(17), iii\u2013iv, ix\u2013xi, 1\u2013165","DOI":"10.3310\/hta10170"},{"issue":"4","key":"2368_CR51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF02354306","volume":"65","author":"JP Lindenmayer","year":"1994","unstructured":"Lindenmayer JP, Bernstein-Hyman R, Grochowski S (1994) A new five factor model of schizophrenia. Psychiatr Q 65(4):299\u2013322","journal-title":"Psychiatr Q"},{"issue":"1","key":"2368_CR52","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000284896","volume":"28","author":"JP Lindenmayer","year":"1995","unstructured":"Lindenmayer JP, Bernstein-Hyman R, Grochowski S, Bark N (1995) Psychopathology of schizophrenia: initial validation of a 5-factor model. Psychopathology 28(1):22\u201331","journal-title":"Psychopathology"},{"key":"2368_CR53","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1176\/ajp.149.12.1666","volume":"149","author":"W Maier","year":"1992","unstructured":"Maier W, Lichtermann D, Minges J, Heun R, Hallmayer J, Benkert O (1992) Schizoaffective disorder and affective disorders with mood-incongruent psychotic features: keep separate or combine? Evidence from a family study. Am J Psychiatry 149:1666\u20131673","journal-title":"Am J Psychiatry"},{"issue":"9","key":"2368_CR54","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1176\/appi.ajp.2007.06091479","volume":"164","author":"D Mamo","year":"2007","unstructured":"Mamo D, Graff A, Mizrahi R, Shammi CM, Romeyer F, Kapur S (2007) Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry 164(9):1411\u20131417","journal-title":"Am J Psychiatry"},{"issue":"1","key":"2368_CR55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S003329170003960X","volume":"10","author":"CD Marsden","year":"1980","unstructured":"Marsden CD, Jenner P (1980) The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med 10(1):55\u201372","journal-title":"Psychol Med"},{"issue":"4","key":"2368_CR56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1192\/bjp.bp.108.050088","volume":"193","author":"DD Miller","year":"2008","unstructured":"Miller DD, Caroff SN, Davis SM, Rosenheck RA, McEvoy JP, Saltz BL, Riggio S, Chakos MH, Swartz MS, Keefe RS, Stroup TS, Lieberman JA, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators (2008) Extrapyramidal side-effects of antipsychotics in a randomised trial. Br J Psychiatry 193(4):279\u2013288","journal-title":"Br J Psychiatry"},{"issue":"2","key":"2368_CR57","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0447.2009.01356.x","volume":"120","author":"J Moncrieff","year":"2009","unstructured":"Moncrieff J, Cohen D, Mason JP (2009) The subjective experience of taking antipsychotic medication: a content analysis of Internet data. Acta Psychiatr Scand 120(2):102\u2013111","journal-title":"Acta Psychiatr Scand"},{"issue":"1\u20133","key":"2368_CR58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2006.08.025","volume":"99","author":"M Mula","year":"2007","unstructured":"Mula M, Pini S, Cassano GB (2007) The neurobiology and clinical significance of depersonalization in mood and anxiety disorders: a critical reappraisal. J Affect Disord 99(1\u20133):91\u201399","journal-title":"J Affect Disord"},{"issue":"6","key":"2368_CR59","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0924-9338(01)00591-0","volume":"16","author":"D Naber","year":"2001","unstructured":"Naber D, Moritz S, Andresen B, Jacobsen D, Mersmann K, Wilke U, Lambert M, Naber D, Krausz M (2001) Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics. Eur Psychiatry 16(6):354\u2013361","journal-title":"Eur Psychiatry"},{"issue":"6","key":"2368_CR60","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1192\/bjp.164.6.834","volume":"164","author":"JW Newcomer","year":"1994","unstructured":"Newcomer JW, Miller LS, Faustman WO, Wetzel MW, Vogler GP, Csernansky JG (1994) Correlations between akathisia and residual psychopathology: a by-product of neuroleptic-induced dysphoria. Br J Psychiatry 164(6):834\u2013838","journal-title":"Br J Psychiatry"},{"issue":"4","key":"2368_CR61","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-3223(93)90288-O","volume":"33","author":"AL Nordstr\u00f6m","year":"1993","unstructured":"Nordstr\u00f6m AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin C, Uppfeldt G (1993) Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry 33(4):227\u2013235","journal-title":"Biol Psychiatry"},{"issue":"3","key":"2368_CR62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00504757","volume":"300","author":"MC Nowycky","year":"1977","unstructured":"Nowycky MC, Roth RH (1977) Presynaptic dopamine receptors. Development of supersensitivity following treatment with fluphenazine decanoate. Naunyn Schmiedebergs Arch Pharmacol 300(3):247\u2013254","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"2368_CR63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/taap.1993.1217","volume":"123","author":"JT Pan","year":"1993","unstructured":"Pan JT, Hooth MJ, Lookingland KJ, Moore KE, Marks TA (1993) Comparison of the effects of losulazine and reserpine on central aminergic neurons. Toxicol Appl Pharmacol 123(1):26\u201333","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"2368_CR64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0920-9964(99)00047-X","volume":"40","author":"V Peralta","year":"1999","unstructured":"Peralta V, Cuesta MJ (1999) Negative, parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophr Res 40(3):245\u2013253","journal-title":"Schizophr Res"},{"key":"2368_CR65","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/10673229409017138","volume":"2","author":"BG Pollock","year":"1994","unstructured":"Pollock BG (1994) Recent developments in drug metabolism of relevance to psychiatrists. Harv Rev Psychiatry 2:204\u2013213","journal-title":"Harv Rev Psychiatry"},{"issue":"5","key":"2368_CR66","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00004850-199709000-00003","volume":"12","author":"M Poyurovsky","year":"1997","unstructured":"Poyurovsky M, Weizman A (1997) Serotonergic agents in the treatment of acute neuroleptic-induced akathisia: open-label study of buspirone and mianserin. Int Clin Psychopharmacol 12(5):263\u2013268","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"2368_CR67","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004714-199906000-00003","volume":"19","author":"JG Ramaekers","year":"1999","unstructured":"Ramaekers JG, Louwerens JW, Muntjewerff ND, Milius H, de Bie A, Rosenzweig P, Patat A, O'Hanlon JF (1999) Psychomotor, cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic. J Clin Psychopharmacol 19(3):209\u2013221","journal-title":"J Clin Psychopharmacol"},{"key":"2368_CR68","first-page":"207","volume-title":"Current developments in psychopharmacology","author":"A Randrup","year":"1975","unstructured":"Randrup A, Munkvad L, Fog R et al (1975) Mania, depression, and brain dopamine. In: Essman WB, Valzelli L (eds) Current developments in psychopharmacology. Spectrum Publications, New York, pp 207\u2013229"},{"issue":"4","key":"2368_CR69","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","volume":"3","author":"BL Roth","year":"2004","unstructured":"Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3(4):353\u2013359","journal-title":"Nat Rev Drug Discov"},{"issue":"1\u20133","key":"2368_CR70","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.schres.2006.03.033","volume":"85","author":"H Saeedi","year":"2006","unstructured":"Saeedi H, Remington G, Christensen BK (2006) Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood. Schizophr Res 85(1\u20133):222\u2013231","journal-title":"Schizophr Res"},{"issue":"1","key":"2368_CR71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0922-4106(95)90169-8","volume":"289","author":"O Schoots","year":"1995","unstructured":"Schoots O, Seeman P, Guan HC, Paterson AD, Van Tol HH (1995) Long-term haloperidol elevates dopamine D4 receptors by 2-fold in rats. Eur J Pharmacol 289(1):67\u201372","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2368_CR72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00004714-198606000-00024","volume":"6","author":"ED Shaw","year":"1986","unstructured":"Shaw ED, Mann JJ, Weiden PJ, Sinsheimer LM, Brunn RD (1986) A case of suicidal and homicidal ideation and akathisia in a double-blind neuroleptic crossover study. J Clin Psychopharmacol 6(3):196\u2013197","journal-title":"J Clin Psychopharmacol"},{"key":"2368_CR73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"GM Simpson","year":"1970","unstructured":"Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11\u201319","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"2368_CR74","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1176\/appi.ajp.157.10.1552","volume":"157","author":"PF Sullivan","year":"2000","unstructured":"Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157:1552\u20131562","journal-title":"Am J Psychiatry"},{"key":"2368_CR75","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.62.11.1228","volume":"62","author":"LK Tremblay","year":"2005","unstructured":"Tremblay LK, Naranjo CA, Graham SJ, Herrmann N, Mayberg HS, Hevenor S, Busto UE (2005) Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 62:1228\u20131236","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"2368_CR76","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0301-0082(00)00033-2","volume":"63","author":"TM Tzschentke","year":"2001","unstructured":"Tzschentke TM (2001) Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 63(3):241\u2013320","journal-title":"Prog Neurobiol"},{"issue":"1","key":"2368_CR77","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archpsyc.1974.01760130049008","volume":"31","author":"T Putten Van","year":"1974","unstructured":"Van Putten T (1974) Why do schizophrenic patients refuse to take their drugs? Arch Gen Psychiatry 31(1):67\u201372","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"2368_CR78","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0893-133X(01)00231-7","volume":"25","author":"NP Verhoeff","year":"2001","unstructured":"Verhoeff NP, Kapur S, Hussey D, Lee M, Christensen B, Psych C, Papatheodorou G, Zipursky RB (2001) A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects. Neuropsychopharmacology 25(2):213\u2013223","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"2368_CR79","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0091-3057(02)01028-6","volume":"74","author":"NP Verhoeff","year":"2003","unstructured":"Verhoeff NP, Christensen BK, Hussey D, Lee M, Papatheodorou G, Kopala L, Rui Q, Zipursky RB, Kapur S (2003) Effects of catecholamine depletion on D2 receptor binding, mood, and attentiveness in humans: a replication study. Pharmacol Biochem Behav 74(2):425\u2013432","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"2368_CR80","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.neuroimage.2005.11.014","volume":"30","author":"I Vernaleken","year":"2006","unstructured":"Vernaleken I, Kumakura Y, Cumming P, Buchholz HG, Siessmeier T, Stoeter P, M\u00fcller MJ, Bartenstein P, Gr\u00fcnder G (2006) Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge. Neuroimage 30(4):1332\u20131339","journal-title":"Neuroimage"},{"issue":"2","key":"2368_CR81","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/JCP.0b013e31820e4832","volume":"31","author":"T Veselinovi\u0107","year":"2011","unstructured":"Veselinovi\u0107 T, Schorn H, Vernaleken IB, Schiffl K, Klomp M, Gr\u00fcnder G (2011) Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion. J Clin Psychopharmacol 31(2):214\u2013220","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"2368_CR82","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-003-1648-y","volume":"171","author":"L Voruganti","year":"2004","unstructured":"Voruganti L, Awad AG (2004) Neuroleptic dysphoria: towards a new synthesis. Psychopharmacology (Berl) 171(2):121\u2013132","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"2368_CR83","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0893-133X(01)00263-9","volume":"25","author":"L Voruganti","year":"2001","unstructured":"Voruganti L, Slomka P, Zabel P, Costa G, So A, Mattar A, Awad AG (2001) Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D(2) binding ratios on SPECT imaging. Neuropsychopharmacology 25(5):642\u2013650","journal-title":"Neuropsychopharmacology"},{"key":"2368_CR84","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/archpsyc.1984.01790120015003","volume":"41","author":"MM Weissman","year":"1984","unstructured":"Weissman MM, Gershon ES, Kidd KK, Prusoff BA, Leckman JF, Dibble E et al (1984) Psychiatric disorders in the relatives of probands with affective disorders: the Yale NIMH collaborative family study. Arch Gen Psychiatry 41:13\u201321","journal-title":"Arch Gen Psychiatry"},{"key":"2368_CR85","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000285058","volume":"30","author":"L White","year":"1997","unstructured":"White L, Harvey PD, Opler L, Lindenmayer JP (1997) Empirical assessment of the factorial structure of clinical in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. Psychopathology 30:263\u2013274","journal-title":"Psychopathology"},{"issue":"1\u20132","key":"2368_CR86","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jneumeth.2004.04.041","volume":"140","author":"T Yoshitake","year":"2004","unstructured":"Yoshitake T, Yoshitake S, Fujino K, Nohta H, Yamaguchi M, Kehr J (2004) High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex. J Neurosci Methods 140(1\u20132):163\u2013168","journal-title":"J Neurosci Methods"},{"key":"2368_CR87","unstructured":"Zerssen DV, K\u00f6ller D-M (1976) Die Befindlichkeitsskala. Parallelformen Bf-S and Bf-S\u00b4.(The well-being scale, Parallelforms Bf-S and Bf-S\u00b4). Beltz, Weinheim"},{"issue":"3","key":"2368_CR88","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0165-1781(98)00114-0","volume":"81","author":"J Zhang-Wong","year":"1998","unstructured":"Zhang-Wong J, Beiser M, Zipursky RB, Bean G (1998) An investigation of ethnic and gender differences in the pharmacodynamics of haloperidol. Psychiatry Res 81(3):333\u2013339","journal-title":"Psychiatry Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-011-2368-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-011-2368-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-011-2368-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T23:20:59Z","timestamp":1741216859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-011-2368-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,4]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2368"],"URL":"https:\/\/doi.org\/10.1007\/s00213-011-2368-3","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,4]]}}}